Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/27/2009 | EP2062593A2 Method for producing preparation containing bioactive peptide |
05/27/2009 | EP2062585A1 The antibiotics composition comprising aminoglycoside antibiotics |
05/27/2009 | EP2062584A1 Adhesive preparation |
05/27/2009 | EP2062582A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
05/27/2009 | EP2062581A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
05/27/2009 | EP2062579A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
05/27/2009 | EP2062576A1 Adhesive preparation |
05/27/2009 | EP2062575A1 Adhesive preparation |
05/27/2009 | EP2062574A1 Composition comprising reduced coenzyme q10 and lysolecithin |
05/27/2009 | EP2062573A1 Abuse resistant opioid containing transdermal systems |
05/27/2009 | EP2062572A1 Pharmaceutical compositions |
05/27/2009 | EP2062571A1 Self-emulsifying pharmaceutical composition with enhanced bioavailability |
05/27/2009 | EP2062570A1 A method for obtaining stable micro-emulsions of derivatives of oxycarotenoids of short-chain organic acids, micro-emulsions obtained, and formulation which contains these |
05/27/2009 | EP2062569A1 Vaginal delivery system |
05/27/2009 | EP2062568A1 Vaginal delivery system |
05/27/2009 | EP2061658A2 Delivery systems and processes for delivering functional compounds to substrates |
05/27/2009 | EP2061583A2 Organic nanoparticles obtained from microemulsions by solvent evaporation |
05/27/2009 | EP2061483A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
05/27/2009 | EP2061463A1 Topical composition comprising a dihydropyridine calcium antagonist |
05/27/2009 | EP2061448A2 Sustained release formulation of naltrexone |
05/27/2009 | EP2061441A2 Transdermal delivery of meptazinol |
05/27/2009 | EP2061440A2 A pharmaceutical composition of tacrolimus |
05/27/2009 | EP2061439A1 Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor |
05/27/2009 | EP2061438A1 Extended release gastro-retentive oral drug delivery system for valsartan |
05/27/2009 | EP2061437A1 Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors |
05/27/2009 | EP2061436A1 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof |
05/27/2009 | EP2061435A2 Polystyrene sulfonate polymer tablets, their preparation and use |
05/27/2009 | EP2061434A2 Engineering shape of polymeric micro-and nanoparticles |
05/27/2009 | EP2061433A2 Compositions and methods for enhancing transport through mucus |
05/27/2009 | EP2061432A1 Nano-vehicle for the transcutaneous transport, preparation containing the same and its use |
05/27/2009 | EP2061431A2 Enhanced immediate release formulations of topiramate |
05/27/2009 | EP2061430A2 Bis (thiohydrazide amides) formulation |
05/27/2009 | EP2061429A2 Method of treating bone cancer |
05/27/2009 | EP2061428A1 Improvements in pharmaceutical compositions |
05/27/2009 | EP2061427A2 Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture |
05/27/2009 | EP2061344A1 Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same |
05/27/2009 | EP2061338A1 Food protein and charged emulsifier interaction |
05/27/2009 | EP1931338A4 Aerosol powder formulation comprising sieved lactose |
05/27/2009 | EP1906896A4 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate |
05/27/2009 | EP1904147A4 Medicament delivery article, accessory&system |
05/27/2009 | EP1878431A4 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
05/27/2009 | EP1789107B1 Medical stent provided with inhibitors of atp synthesis |
05/27/2009 | EP1742614B1 Embolic particles |
05/27/2009 | EP1711158B1 Otic detergent composition for animals, with edta and chlorexhidine |
05/27/2009 | EP1684720B1 Introducing aerosol into a ventilator circuit |
05/27/2009 | EP1635770B1 Antifungal nail coat and method of use |
05/27/2009 | EP1606381B1 Coated enzyme granules |
05/27/2009 | EP1578350B1 Sustained-release gel coated compositions |
05/27/2009 | EP1526841B1 Galenic formulation for colon targeted delivery of active principles |
05/27/2009 | EP1509246B1 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
05/27/2009 | EP1485080B1 Use of adapalene for the treatment of dermatological disorders |
05/27/2009 | EP1404304B1 Tablet comprising cetirizine and pseudoephedrine |
05/27/2009 | EP1366075B1 New interferon beta-like molecules |
05/27/2009 | EP1299086A4 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
05/27/2009 | EP1267830B1 Method for preparing high pressure/high shear dispersions containing physiologically active ingredients |
05/27/2009 | EP1130966B2 Antiparasitic formulations |
05/27/2009 | CN201244290Y Multiplex charge device for preparing electrostatic medicine composite membrane for treating diabetic foot |
05/27/2009 | CN201244205Y Dual-purpose patches for external use |
05/27/2009 | CN201244128Y Plaster with various medical layers for application therapy |
05/27/2009 | CN101443436A Process for the preparation of water-in-oil and oil-in-water nanoemulsions |
05/27/2009 | CN101443015A Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty |
05/27/2009 | CN101442993A Adhesive preparation |
05/27/2009 | CN101442992A Dosage forms having a randomized coating |
05/27/2009 | CN101442991A Sustained-release nanoparticle compositions and methods for using the same |
05/27/2009 | CN101442990A New form of administration of racecadotril |
05/27/2009 | CN101442989A Compositions comprising amphotericin B |
05/27/2009 | CN101442988A Granular formulation |
05/27/2009 | CN101442987A Compositions and methods for treating dermatological conditions |
05/27/2009 | CN101442986A Hydrogel suspension and manufacturing process thereof |
05/27/2009 | CN101442985A Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
05/27/2009 | CN101442984A Vaginal drug delivery system and method |
05/27/2009 | CN101442983A Drug depot implant designs and methods of implantation |
05/27/2009 | CN101442982A Stomach floater composition containing optimization treated starch for inducing satiation sense |
05/27/2009 | CN101442974A Paste for use as a bandage on mucous membranes of the oral cavity or on the skin |
05/27/2009 | CN101441161A Particle-stabilised emulsions |
05/27/2009 | CN101439217A Negative ion dysmenorrheal-nursing piece |
05/27/2009 | CN101439188A Polymer lyophilized preparation of insoluble anti-tumor medicament |
05/27/2009 | CN101439187A Novel coupling compound of bile acid and anti-hepatitis virus medicament and medical use thereof |
05/27/2009 | CN101439182A Somatostatin receptor mediated tumor-targeted medicament composition |
05/27/2009 | CN101439176A Chinese medicine pills for treating acute cholecystitis |
05/27/2009 | CN101439172A Chinese medicinal composition and preparation method thereof and quality control method |
05/27/2009 | CN101439165A Plaster for treating bone fracture and preparation method thereof |
05/27/2009 | CN101439159A Chinese medicinal composition for treating nephropathy and preparation thereof |
05/27/2009 | CN101439147A Haiqihuang granules as well as preparation method thereof and pharmacy use |
05/27/2009 | CN101439143A Chinese medicine granules containing Anemarrhena asphodefoides extract and preparation method thereof |
05/27/2009 | CN101439141A Use of longstamen onion bulb in preparing medicament for treating vascular endothelial dysfunction |
05/27/2009 | CN101439140A Medicament containing longstamen onion bulb for treating vascular endothelial dysfunction and preparation method thereof |
05/27/2009 | CN101439136A Plaster for treating bone disease and soft tissue injury |
05/27/2009 | CN101439135A Chinese medicine granule containing extract of grassleaved sweetflag rhizome and preparation method thereof |
05/27/2009 | CN101439134A Method for preparing Chinese medicine preparation |
05/27/2009 | CN101439129A Pure Chinese medicinal preparation for curing sterility and its preparation process |
05/27/2009 | CN101439128A Technique for preparing Linggui plaster |
05/27/2009 | CN101439126A Chinese medicine granule containing Huangyangning and preparation method thereof |
05/27/2009 | CN101439122A Chinese medicine granule containing prepared rehmannia root extract and preparation method thereof |
05/27/2009 | CN101439121A Pure medicinal formulation for stopping smoking |
05/27/2009 | CN101439117A Chinese medicine for treating enterospasm of children |
05/27/2009 | CN101439116A Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction |
05/27/2009 | CN101439107A Chinese medicine granule containing haw thorn extract and preparation method thereof |
05/27/2009 | CN101439105A Chinese medicine granule containing spina date seed extract and preparation method thereof |
05/27/2009 | CN101439102A 'Mashe' oil rheumatalgia-relieving plaster |